A methodology we’re currently establishing to determine serum iron after administration of a colloidal form of iron (i.e. Ferric carboxymaltose) used in the treatment of anaemia.
Looking for exceptional Pharmacokinetic, Bioequivalent, Toxicokinetic or Residual studies?
Thanks to our advanced technology, techniques, and highly sensitive ICP/MS tech, QUINTA-ANALYTICA’s bioanalytical department is capable of conducting elemental analyses of extremely minute trace elements in biological matrices such as urine, plasma, blood serum & tissues.
With very low detection limits in the order of parts per billion, we can determine the given element not only in terms of total concentration, but also the form in which the monitored element is contained in the given matrix (using speciation analysis). This is essential for assessing the efficacy of drugs or dietary supplements containing trace elements.
A perfect example: a methodology we’re currently establishing to determine serum iron after administration of a colloidal form of iron (i.e. Ferric carboxymaltose) used in the treatment of anaemia. Our analyses can be used to determine both total iron in the blood serum plus its individual forms (labile iron, iron bound to transferrin, colloidal iron).
We think that’s pretty cool!
Curious to know how we do it, or more about our services? Get in touch.
18 July 2023
Challenges of a large-scale study of breast cancer
Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.
29 June 2023
EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.
After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.
22 June 2023
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency